Latest News for: sjd
Edit
Hastings Tribune
28 Oct 2025
Trawick International Expands Access to World-Class Medical Care Through Partnership with SJD
28, 2025 (GLOBE NEWSWIRE) -- Trawick International, a ...
Edit
Trawick International Expands Access to World-Class Medical Care Through Partnership with SJD Barcelona Children’s Hospital
Nasdaq Globe Newswire 28 Oct 2025
Trawick International partners with SJD Barcelona Children’s Hospital to expand global access to world-class pediatric care and telemedicine benefits ... .
Edit
The Berkshire Eagle
25 Oct 2025
Published in The Lancet: Nipocalimab significantly decreased Sjögren's disease (SjD) activity and severity through substantial ...
Nipocalimab, a first-in-class FcRn blocker being ...
Edit
Published in The Lancet: Nipocalimab significantly decreased Sjögren’s disease (SjD) activity and severity through substantial reduction in Sjögren’s-related autoantibodies (Johnson & Johnson)
Public Technologies 25 Oct 2025
Nipocalimab significantly decreased Sjögren's disease (SjD) activity and severity through substantial reduction in Sjögren's-related autoantibodies Innovative Medicine ... Food and Drug Administration (FDA) for SjD (November 2024).
Edit
Published in The Lancet: Nipocalimab significantly decreased Sjögren's disease (SjD) activity and severity through substantial reduction in Sjögren's-related autoantibodies
PR Newswire 24 Oct 2025
Critical patient-reported SjD symptoms including dryness, pain and fatigue trended towards greater improvement in the nipocalimab-treated group compared to placebo-treated patients ... Food and Drug Administration (FDA) for SjD (November 2024).
- 1